Ns. Verkaik et al., Down-regulation of CD44 expression in human prostatic carcinoma cell linesis correlated with DNA hypermethylation, INT J CANC, 80(3), 1999, pp. 439-443
Down-regulation of the cell-surface adhesion molecule CD44 has been suggest
ed to play an important role in tumor progression and metastasis of prostat
e cancer. CD44 is encoded by a gene that contains a CpG-rich region (CpG is
land) in its 5' regulatory sequence. We tried to assess whether hypermethyl
ation of this region is the mechanism responsible for CD44 transcriptional
inactivation. A panel of prostatic-carcinoma cell lines, Du 145, LNCaP, PC3
, PC346C and TSU, was analyzed for CD44 mRNA and protein expression. Du 145
, PC3 and TSU were positive for CD44, whereas in LNCaP and PC346C both CD44
mRNA and protein expression was suppressed. Methylation-sensitive restrict
ion-enzyme analysis of genomic DNA showed that, in contrast to the CD44-pos
itive cell lines, the CD44-negative lines were hypermethylated in the CD44
promoter CpG island. Furthermore, treatment of a PC346C culture with the de
methylating agent 5-azacytidine resulted in re-expression of CD44 mRNA. It
is concluded that hypermethylation of the CD44 5' promoter region is one of
the mechanisms by which CD44 expression is down-regulated in prostatic-car
cinoma cell lines. (C) 1999 Wiley-Liss, Inc.